Monoclonal Antibody to N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP)
NT-Pro-BNP; ; N-BNP
- Product No.MAA485Hu28
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- SourceMonoclonal antibody preparation
- Potency (Clone Number)C8
- Ig Isotype IgG2b Kappa
- PurificationProtein A + Protein G affinity chromatography
- Immunogen CPA485Hu21-OVA Conjugated N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP)
- Buffer FormulationPBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
- Organism Species MoreSus scrofa; Porcine (Pig)
- ApplicationsWB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
- DownloadInstruction Manual
- UOM 20µl100µl 200µl 1ml 10ml
For more details, please contact local distributors! US$ 258
For more details, please contact local distributors! US$ 368
For more details, please contact local distributors! US$ 920
For more details, please contact local distributors! US$ 3680
For more details, please contact local distributors!
The antibody is a mouse monoclonal antibody raised against NT-ProBNP. It has been selected for its ability to recognize NT-ProBNP in immunohistochemical staining and western blotting.
Western blotting: 0.5-2µg/mL;1:500-2000
Optimal working dilutions must be determined by end user.
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
|Eur Rev Med Pharmacol Sci.||The role of serum n-terminal pro-brain natriuretic peptide in transient tachypnea of the newborn Europeanreview: Source|
|Transplantation Proceedings||Vascular Adhesion Protein-1, a Novel Molecule, in Kidney and Heart Allograft Recipients Pubmed: 23769096|
|34||Paradoxical low-flow, low-gradient aortic stenosis despite preserved left ventricular ejection fraction: new insights from weights of operatively excised aortic valves Pubmed: 24755006|
|Integrative Medicine Insights||A Randomized Controlled Trial to Study the Effect of Yoga Therapy on Cardiac Function and N Terminal Pro BNP in Heart Failure NCBI: PMC3981569|
|Liver Int.?||Diabetes enhances the intrahepatic vascular response to endothelin-1 in cirrhotic rats: association with the ETA receptor and pERK up-regulation. Pubmed:24636620|
|Eur J Heart Fail.||Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. Pubmed:24903195|
|Scientific Reports||Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension PubMed: 25747153|
|Int J Mol Sci||The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension PubMed: 25984599|
|scientific reports||Effect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone PubMed: 26477337|
|Liver Int||Diabetes enhances the intrahepatic vascular response to endothelin‐1 in cirrhotic rats: association with the ETA receptor and pERK up‐regulation PubMed: 24636620|
|Int J Clin Exp Pathol||Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction PubMed: 26261541|
|Iranian Journal of Pediatrics||NT-proBNP in Children With Left to Right Shunt and Dilated Cardiomyopathy serve:4485|
|International Journal of Cardiology||Human myoblast transplantation in mice infarcted heart alters the expression profile of cardiac genes associated with left ventricle remodeling Pubmed:26457413|
|IJC Heart & Vasculature||Cardiovascular changes in patients with non-severe Plasmodium vivax malaria article:S2352-9067(16)30010-0|
|Heart Lung Circ||Soluble Glycoprotein 130 and Heat Shock Protein 27 as Novel Candidate Biomarkers of Chronic Heart Failure with Preserved Ejection Fraction Pubmed:27067668|
|International journal of cardiology||Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies. pubmed:27448535|
|Experimental and Therapeutic Medicine||Expression of pericardial fluid T-cells and related inflammatory cytokines in patients with chronic heart failure. pubmed:28565777|
|Journal of Cardiovascular Electrophysiology||Effect of Cardiac Resynchronization Therapy on Myocardial Fibrosis and Relevant Cytokines in a Canine Model With Experimental Heart Failure. pubmed:28127817|
|Journal of Cardiovascular Ecography||Study of Vitamin D Status in Patients with Dilated Cardiomyopathy at a Teaching Hospital in North India. pubmed:28465969|
|International Journal of Cardiology||5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - apreliminary approach to clinical utility. pubmed:27526355|
|Cardiovasc Toxicol||Beneficial Effects of Ozone Therapy on Oxidative Stress, Cardiac Functions and Clinical Findings in Patients with Heart Failure Reduced Ejection Fraction pubmed:28097518|
|Sci Rep.||Serial heart rhythm complexity changes in patients with anterior wall ST segment elevation myocardial infarction. pubmed:28252107|
|Journal of Cardiovascular Magnetic Resonance||The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study pubmed:28065166|
|Repositório Institucional UNESP||AVALIAÇÃO ELETROCARDIOGRÁFICA AMBULATORIAL DE CÃES COM EHRLIQUIOSE MONOCÍTICA CRÔNICA handle:11449|
|Archivos de medicina veterinaria||Cardiac biomarkers in dogs with visceral leishmaniasis S0301-732X2016000300004|
|Original article||Evaluation of N-Terminal Pro Brain Natriuretic Peptide as a biomarker for clinical severity of heart failure in pediatric population Attach432|
|Evidence-Based Complementary and Alternative Medicine||Cardioprotection against Heart Failure by Shenfu Injection via TGF-β/Smads Signaling Pathway pubmed:28698735|
|Scientific Reports||QSKL protects against myocardial apoptosis on heart failure via PI3K/Akt-p53 signaling pathway. pubmed:29209026|
|Vascular Pharmacology||Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats pubmed:29100963|
|Evidence-based complementary and alternative medicine||Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats pubmed:28706558|
|Europace||Prediction of electro-anatomical substrate using APPLE score and biomarkers Pubmed:29893827|
|Heart Rhythm||Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes Pubmed:29604419|
|American Journal of Hypertension||MicroRNAs in Peripheral Mononuclear Cells as Potential Biomarkers in Hypertensive Patients With Heart Failure With Preserved Ejection Fraction Pubmed:29506053|
|International Journal of Molecular Medicine||Differential microRNA expression profiles and bioinformatics analysis between young and aging spontaneously hypertensive rats Pubmed:29328372|
|Biomarkers||Regulation of circulating chromogranin B levels in heart failure Pubmed:29098879|
|Lung||Effect of 6-min Walk Test on pro-BNP Levels in Patients with Pulmonary Arterial Hypertension Pubmed:29564533|
|International Journal of Clinical and Exp Medicine||Dynamic monitoring the level of NT-proBNP in assessing the value of cardiac function and prognosis in patients with systemic infection ijcem0072283.pdf|